Search Results 891-900 of 16014 for melatonin receptor agonists

  1. Overview - Anticancer Drug Action Laboratory - Mayo Clinic Research

    The Anticancer Drug Action Lab of Scott Kaufmann, M.D., Ph.D., at Mayo Clinic studies the mechanism of action of anti-cancer drugs, tumor cell sensitivity, ...

  2. Study Evaluating the Safety and Efficacy of Fenfluramine Hydrochloride Oral Solution (ZX008)as Adjunctive Therapy in Children with Intractable Epilepsy with Myoclonic-Atonic Seizures - Mayo Clinic

    The purpose of this study is to document the effectiveness of ZX008 as adjunctive therapy by documenting percent reduction in convulsive seizures and drop ...

  3. A Study of the Effectiveness and Safety of Pembrolizumab (MK-3475) for Women with Advanced Recurrent Ovarian Cancer - Mayo Clinic

    ... receptor (e.g. cytotoxic T-lymphocyte-associated antigen-4 [CTLA-4], tumor necrosis factor receptors OX-40 or CD137); Has participated in prior pembrolizumab ...

  4. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

    In this study, participants with relapsed or refractory primary mediastinal large B-cell lymphoma (rrPMBCL) or relapsed or refractory Richter Syndrome (rrRS) ...

  5. Epilepsy: The next generation of neurostimulation therapies - Mayo Clinic

    Translating neurostimulation research and innovations into patient care is the overarching goal of Kai J. Miller, M.D., Ph.D., and Dora Hermes, Ph.D., ...

  6. A Study of Lenalidomide Combined with a Standard Chemotherapy for Treating Patients with Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma - Mayo Clinic

    Lenalidomide may stop the growth of peripheral T-cell non-Hodgkin's lymphoma by blocking the growth of new blood vessels necessary for cancer growth. Giving ...

  7. A Blood Collection Protocol to Study the Immune Responses of Cancer Patients with Malignancies - Mayo Clinic

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  8. Selpercatinib (oral route) - Mayo Clinic

    Selpercatinib is used to treat locally advanced or metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) in patients whose tumors have ...

  9. Mayo Clinic

    Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

  10. Ergotamine (oral route) - Mayo Clinic

    Ergotamine is used to treat or prevent vascular headaches, including migraine, migraine variants, or histaminic cephalalgia. It will not relieve pain other than ...